Chudenko (1941) Q4 2025 earnings summary

Executive summary

• Achieved record highs in net sales and profit attributable to owners of parent for FY2024, surpassing initial targets despite high raw material and labor costs.

• Net sales rose 10.4% year-over-year to ¥221,885 million for the fiscal year ended March 31, 2025.

• Strengthened business foundation in the Chugoku region and expanded in urban areas, with notable growth in orders and net sales.

• Formed a business alliance with IAQ in Malaysia and received multiple certifications for health and diversity initiatives.

• Comprehensive income reached ¥22,075 million, up 16.2% year-over-year.

Financial highlights

• FY2024 consolidated net sales rose to ¥221.8 billion, up ¥20.8 billion year-over-year (110%).

• Operating profit increased by ¥9.7 billion to ¥21.6 billion (182% YoY); ordinary profit up ¥10.6 billion to ¥23.4 billion (184% YoY).

• Gross profit increased from ¥28,529 million to ¥38,928 million year-over-year.

• Balance sheet: total assets grew to ¥293.9 billion, equity ratio improved to 77.1%.

• Cash and cash equivalents at year-end were ¥34,435 million, up from ¥29,845 million.

Outlook and guidance

• FY2025 consolidated net sales forecasted at ¥230.0 billion (+¥8.1 billion YoY), operating profit at ¥22.0 billion (+¥0.3 billion YoY).

• Profit attributable to owners of parent expected to decrease to ¥15.8 billion due to absence of prior year’s tax benefit.

• Medium-Term Management Plan 2027 targets FY2027 net sales of ¥240.0 billion, operating profit of ¥23.0 billion, and ROE of 7.0% or higher.

• Basic earnings per share forecast is ¥291.82.